nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—HRH2—coronary artery disease	0.245	0.724	CbGaD
Doxepin—CYP2C19—coronary artery disease	0.0517	0.153	CbGaD
Doxepin—HTR2A—coronary artery disease	0.0419	0.124	CbGaD
Doxepin—ORM1—Penbutolol—coronary artery disease	0.0296	0.0807	CbGbCtD
Doxepin—ORM1—Pitavastatin—coronary artery disease	0.0259	0.0706	CbGbCtD
Doxepin—HTR1A—Penbutolol—coronary artery disease	0.0193	0.0526	CbGbCtD
Doxepin—ABCB1—Ticagrelor—coronary artery disease	0.0105	0.0288	CbGbCtD
Doxepin—CYP2C9—Fenofibrate—coronary artery disease	0.00968	0.0264	CbGbCtD
Doxepin—CYP2C19—Gemfibrozil—coronary artery disease	0.00931	0.0254	CbGbCtD
Doxepin—CYP1A2—Gemfibrozil—coronary artery disease	0.00859	0.0234	CbGbCtD
Doxepin—CYP2C19—Clopidogrel—coronary artery disease	0.00807	0.022	CbGbCtD
Doxepin—CYP2C9—Gemfibrozil—coronary artery disease	0.00774	0.0211	CbGbCtD
Doxepin—KCNH2—purkinje fiber—coronary artery disease	0.0077	0.192	CbGeAlD
Doxepin—CYP1A2—Clopidogrel—coronary artery disease	0.00745	0.0203	CbGbCtD
Doxepin—CYP2C19—Telmisartan—coronary artery disease	0.00705	0.0192	CbGbCtD
Doxepin—CYP2C9—Clopidogrel—coronary artery disease	0.00671	0.0183	CbGbCtD
Doxepin—ABCB1—Clopidogrel—coronary artery disease	0.00651	0.0178	CbGbCtD
Doxepin—ABCB1—Perindopril—coronary artery disease	0.00651	0.0178	CbGbCtD
Doxepin—CYP3A4—Ticagrelor—coronary artery disease	0.00632	0.0172	CbGbCtD
Doxepin—CYP2C9—Pitavastatin—coronary artery disease	0.00587	0.016	CbGbCtD
Doxepin—CYP2C9—Valsartan—coronary artery disease	0.00571	0.0156	CbGbCtD
Doxepin—ABCB1—Pitavastatin—coronary artery disease	0.00569	0.0155	CbGbCtD
Doxepin—ABCB1—Telmisartan—coronary artery disease	0.00569	0.0155	CbGbCtD
Doxepin—CYP2C19—Timolol—coronary artery disease	0.00569	0.0155	CbGbCtD
Doxepin—CYP3A4—Fenofibrate—coronary artery disease	0.00563	0.0154	CbGbCtD
Doxepin—ABCB1—Enalapril—coronary artery disease	0.0054	0.0147	CbGbCtD
Doxepin—ABCB1—Lisinopril—coronary artery disease	0.0054	0.0147	CbGbCtD
Doxepin—CYP2C19—Rosuvastatin—coronary artery disease	0.0052	0.0142	CbGbCtD
Doxepin—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00507	0.0138	CbGbCtD
Doxepin—HTR2B—cardial valve—coronary artery disease	0.00497	0.124	CbGeAlD
Doxepin—CYP2C19—Simvastatin—coronary artery disease	0.00483	0.0132	CbGbCtD
Doxepin—CYP2C19—Lovastatin—coronary artery disease	0.00473	0.0129	CbGbCtD
Doxepin—CYP2D6—Niacin—coronary artery disease	0.00465	0.0127	CbGbCtD
Doxepin—ABCB1—Timolol—coronary artery disease	0.00459	0.0125	CbGbCtD
Doxepin—CYP3A4—Gemfibrozil—coronary artery disease	0.0045	0.0123	CbGbCtD
Doxepin—CYP2C9—Rosuvastatin—coronary artery disease	0.00432	0.0118	CbGbCtD
Doxepin—CYP2D6—Timolol—coronary artery disease	0.00432	0.0118	CbGbCtD
Doxepin—CYP2C19—Atorvastatin—coronary artery disease	0.00431	0.0118	CbGbCtD
Doxepin—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00421	0.0115	CbGbCtD
Doxepin—ABCB1—Ezetimibe—coronary artery disease	0.0042	0.0114	CbGbCtD
Doxepin—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00409	0.0112	CbGbCtD
Doxepin—ABCB1—Captopril—coronary artery disease	0.00404	0.011	CbGbCtD
Doxepin—CYP2C9—Simvastatin—coronary artery disease	0.00402	0.011	CbGbCtD
Doxepin—KCNH2—endocardium—coronary artery disease	0.00397	0.0991	CbGeAlD
Doxepin—CYP2C19—Losartan—coronary artery disease	0.00394	0.0108	CbGbCtD
Doxepin—CYP2C9—Lovastatin—coronary artery disease	0.00393	0.0107	CbGbCtD
Doxepin—CYP2C9—Pravastatin—coronary artery disease	0.00393	0.0107	CbGbCtD
Doxepin—CYP3A4—Clopidogrel—coronary artery disease	0.0039	0.0106	CbGbCtD
Doxepin—ABCB1—Simvastatin—coronary artery disease	0.0039	0.0106	CbGbCtD
Doxepin—ABCB1—Pravastatin—coronary artery disease	0.00382	0.0104	CbGbCtD
Doxepin—ABCB1—Lovastatin—coronary artery disease	0.00382	0.0104	CbGbCtD
Doxepin—CYP2D6—Captopril—coronary artery disease	0.00381	0.0104	CbGbCtD
Doxepin—CYP2D6—Simvastatin—coronary artery disease	0.00368	0.01	CbGbCtD
Doxepin—CYP1A2—Losartan—coronary artery disease	0.00364	0.00992	CbGbCtD
Doxepin—CYP3A4—Eplerenone—coronary artery disease	0.00363	0.0099	CbGbCtD
Doxepin—CYP2D6—Lovastatin—coronary artery disease	0.0036	0.00981	CbGbCtD
Doxepin—CYP2D6—Pravastatin—coronary artery disease	0.0036	0.00981	CbGbCtD
Doxepin—CYP2C9—Atorvastatin—coronary artery disease	0.00358	0.00978	CbGbCtD
Doxepin—ABCB1—Atorvastatin—coronary artery disease	0.00348	0.00949	CbGbCtD
Doxepin—CYP2C9—Losartan—coronary artery disease	0.00328	0.00894	CbGbCtD
Doxepin—CYP2D6—Atorvastatin—coronary artery disease	0.00328	0.00894	CbGbCtD
Doxepin—CYP3A4—Enalapril—coronary artery disease	0.00323	0.00882	CbGbCtD
Doxepin—CYP2C9—cardial valve—coronary artery disease	0.00322	0.0805	CbGeAlD
Doxepin—ABCB1—Losartan—coronary artery disease	0.00318	0.00868	CbGbCtD
Doxepin—CYP3A4—Rosuvastatin—coronary artery disease	0.00251	0.00686	CbGbCtD
Doxepin—CYP3A4—Ezetimibe—coronary artery disease	0.00251	0.00686	CbGbCtD
Doxepin—CYP3A4—Simvastatin—coronary artery disease	0.00234	0.00638	CbGbCtD
Doxepin—CYP3A4—Lovastatin—coronary artery disease	0.00229	0.00624	CbGbCtD
Doxepin—CYP3A4—Pravastatin—coronary artery disease	0.00229	0.00624	CbGbCtD
Doxepin—CYP3A4—Atorvastatin—coronary artery disease	0.00208	0.00568	CbGbCtD
Doxepin—CYP3A4—Losartan—coronary artery disease	0.00191	0.0052	CbGbCtD
Doxepin—SLC6A2—sympathetic nervous system—coronary artery disease	0.00174	0.0434	CbGeAlD
Doxepin—HTR2A—arteriole—coronary artery disease	0.00164	0.041	CbGeAlD
Doxepin—SLC6A2—autonomic nervous system—coronary artery disease	0.00117	0.0292	CbGeAlD
Doxepin—HTR2A—pulmonary artery—coronary artery disease	0.00108	0.0268	CbGeAlD
Doxepin—HTR2A—sympathetic nervous system—coronary artery disease	0.00105	0.0261	CbGeAlD
Doxepin—HTR2A—vagus nerve—coronary artery disease	0.00101	0.0253	CbGeAlD
Doxepin—HTR2A—vein—coronary artery disease	0.000978	0.0244	CbGeAlD
Doxepin—Phenindione—VKORC1—coronary artery disease	0.000941	0.312	CrCbGaD
Doxepin—HRH4—blood—coronary artery disease	0.000823	0.0206	CbGeAlD
Doxepin—HTR2A—autonomic nervous system—coronary artery disease	0.000703	0.0176	CbGeAlD
Doxepin—Olopatadine—S100B—coronary artery disease	0.000465	0.154	CrCbGaD
Doxepin—HRH2—heart—coronary artery disease	0.000463	0.0116	CbGeAlD
Doxepin—HRH2—cardiovascular system—coronary artery disease	0.000437	0.0109	CbGeAlD
Doxepin—HTR2A—artery—coronary artery disease	0.000399	0.00995	CbGeAlD
Doxepin—HRH2—cardiac atrium—coronary artery disease	0.000396	0.00989	CbGeAlD
Doxepin—HRH2—blood—coronary artery disease	0.000345	0.00863	CbGeAlD
Doxepin—HTR2A—endothelium—coronary artery disease	0.000337	0.00841	CbGeAlD
Doxepin—KCNH2—cardiac ventricle—coronary artery disease	0.000334	0.00834	CbGeAlD
Doxepin—ADRA2C—cardiac ventricle—coronary artery disease	0.00033	0.00823	CbGeAlD
Doxepin—KCNH2—myocardium—coronary artery disease	0.000314	0.00785	CbGeAlD
Doxepin—ADRA2C—myocardium—coronary artery disease	0.00031	0.00774	CbGeAlD
Doxepin—CHRM2—heart—coronary artery disease	0.000304	0.00758	CbGeAlD
Doxepin—CHRM2—cardiovascular system—coronary artery disease	0.000286	0.00715	CbGeAlD
Doxepin—HTR2B—heart—coronary artery disease	0.000275	0.00686	CbGeAlD
Doxepin—CHRM1—cardiovascular system—coronary artery disease	0.000261	0.00651	CbGeAlD
Doxepin—HTR2B—cardiovascular system—coronary artery disease	0.000259	0.00648	CbGeAlD
Doxepin—ORM1—blood—coronary artery disease	0.000243	0.00607	CbGeAlD
Doxepin—HTR1A—cardiovascular system—coronary artery disease	0.000232	0.0058	CbGeAlD
Doxepin—ADRA1A—heart—coronary artery disease	0.000227	0.00567	CbGeAlD
Doxepin—KCNH2—heart—coronary artery disease	0.000219	0.00548	CbGeAlD
Doxepin—ADRA2C—heart—coronary artery disease	0.000216	0.0054	CbGeAlD
Doxepin—ADRA1A—cardiovascular system—coronary artery disease	0.000214	0.00535	CbGeAlD
Doxepin—SLC6A4—blood—coronary artery disease	0.000207	0.00517	CbGeAlD
Doxepin—KCNH2—cardiovascular system—coronary artery disease	0.000207	0.00517	CbGeAlD
Doxepin—HTR2B—blood—coronary artery disease	0.000205	0.00512	CbGeAlD
Doxepin—Clomipramine—HRH2—coronary artery disease	0.00019	0.0631	CrCbGaD
Doxepin—KCNH2—cardiac atrium—coronary artery disease	0.000188	0.00468	CbGeAlD
Doxepin—ADRA2C—cardiac atrium—coronary artery disease	0.000185	0.00462	CbGeAlD
Doxepin—CYP2C9—heart—coronary artery disease	0.000178	0.00445	CbGeAlD
Doxepin—ADRA2A—heart—coronary artery disease	0.000173	0.00431	CbGeAlD
Doxepin—CYP2C19—blood—coronary artery disease	0.000172	0.00428	CbGeAlD
Doxepin—ADRA1A—blood—coronary artery disease	0.000169	0.00423	CbGeAlD
Doxepin—CYP2C9—cardiovascular system—coronary artery disease	0.000168	0.0042	CbGeAlD
Doxepin—KCNH2—blood—coronary artery disease	0.000164	0.00409	CbGeAlD
Doxepin—ADRA2C—blood—coronary artery disease	0.000161	0.00403	CbGeAlD
Doxepin—ADRA2A—cardiac atrium—coronary artery disease	0.000148	0.00369	CbGeAlD
Doxepin—HTR2A—heart—coronary artery disease	0.000147	0.00367	CbGeAlD
Doxepin—CYP1A2—blood—coronary artery disease	0.00014	0.0035	CbGeAlD
Doxepin—HTR2A—cardiovascular system—coronary artery disease	0.000139	0.00346	CbGeAlD
Doxepin—CYP2C9—blood—coronary artery disease	0.000133	0.00332	CbGeAlD
Doxepin—Amitriptyline—HRH2—coronary artery disease	0.000129	0.0428	CrCbGaD
Doxepin—ADRA2A—blood—coronary artery disease	0.000129	0.00322	CbGeAlD
Doxepin—HTR2A—blood—coronary artery disease	0.00011	0.00274	CbGeAlD
Doxepin—CYP3A4—blood—coronary artery disease	0.000101	0.00253	CbGeAlD
Doxepin—CYP2D6—blood—coronary artery disease	9.98e-05	0.00249	CbGeAlD
Doxepin—ABCB1—heart—coronary artery disease	9.62e-05	0.0024	CbGeAlD
Doxepin—ABCB1—cardiovascular system—coronary artery disease	9.08e-05	0.00227	CbGeAlD
Doxepin—Desipramine—SLC22A3—coronary artery disease	8.19e-05	0.0272	CrCbGaD
Doxepin—Clomipramine—GSTP1—coronary artery disease	7.89e-05	0.0262	CrCbGaD
Doxepin—ABCB1—blood—coronary artery disease	7.18e-05	0.00179	CbGeAlD
Doxepin—Oxcarbazepine—CYP2C19—coronary artery disease	6.98e-05	0.0232	CrCbGaD
Doxepin—Imipramine—SLC22A3—coronary artery disease	6.94e-05	0.023	CrCbGaD
Doxepin—Amitriptyline—OPRD1—coronary artery disease	6.8e-05	0.0226	CrCbGaD
Doxepin—Cyclobenzaprine—HTR2A—coronary artery disease	6.18e-05	0.0205	CrCbGaD
Doxepin—Desipramine—ADRB1—coronary artery disease	4.45e-05	0.0148	CrCbGaD
Doxepin—Imipramine—HTR7—coronary artery disease	4.41e-05	0.0146	CrCbGaD
Doxepin—Amitriptyline—HTR7—coronary artery disease	4.38e-05	0.0145	CrCbGaD
Doxepin—Thiothixene—HTR2A—coronary artery disease	4.11e-05	0.0136	CrCbGaD
Doxepin—Clomipramine—CYP2C19—coronary artery disease	4.01e-05	0.0133	CrCbGaD
Doxepin—Nortriptyline—CYP2C19—coronary artery disease	3.92e-05	0.013	CrCbGaD
Doxepin—Oxcarbazepine—ALB—coronary artery disease	3.87e-05	0.0128	CrCbGaD
Doxepin—Desipramine—ADRB2—coronary artery disease	3.75e-05	0.0124	CrCbGaD
Doxepin—Trimipramine—CYP2C19—coronary artery disease	3.69e-05	0.0122	CrCbGaD
Doxepin—Asthenia—Niacin—coronary artery disease	3.65e-05	0.000251	CcSEcCtD
Doxepin—Fatigue—Losartan—coronary artery disease	3.65e-05	0.000251	CcSEcCtD
Doxepin—Headache—Ezetimibe—coronary artery disease	3.64e-05	0.00025	CcSEcCtD
Doxepin—Malaise—Lisinopril—coronary artery disease	3.64e-05	0.00025	CcSEcCtD
Doxepin—Oedema—Ramipril—coronary artery disease	3.63e-05	0.000249	CcSEcCtD
Doxepin—Vertigo—Lisinopril—coronary artery disease	3.62e-05	0.000249	CcSEcCtD
Doxepin—Diphenhydramine—CYP2C19—coronary artery disease	3.62e-05	0.012	CrCbGaD
Doxepin—Dry mouth—Timolol—coronary artery disease	3.62e-05	0.000249	CcSEcCtD
Doxepin—Pain—Losartan—coronary artery disease	3.62e-05	0.000249	CcSEcCtD
Doxepin—Constipation—Losartan—coronary artery disease	3.62e-05	0.000249	CcSEcCtD
Doxepin—Syncope—Lisinopril—coronary artery disease	3.62e-05	0.000248	CcSEcCtD
Doxepin—Vomiting—Eplerenone—coronary artery disease	3.62e-05	0.000248	CcSEcCtD
Doxepin—Feeling abnormal—Furosemide—coronary artery disease	3.61e-05	0.000248	CcSEcCtD
Doxepin—Leukopenia—Lisinopril—coronary artery disease	3.61e-05	0.000248	CcSEcCtD
Doxepin—Nausea—Fenofibrate—coronary artery disease	3.6e-05	0.000248	CcSEcCtD
Doxepin—Pruritus—Niacin—coronary artery disease	3.6e-05	0.000247	CcSEcCtD
Doxepin—Asthenia—Pravastatin—coronary artery disease	3.59e-05	0.000247	CcSEcCtD
Doxepin—Gastrointestinal pain—Furosemide—coronary artery disease	3.59e-05	0.000246	CcSEcCtD
Doxepin—Rash—Eplerenone—coronary artery disease	3.59e-05	0.000246	CcSEcCtD
Doxepin—Urticaria—Perindopril—coronary artery disease	3.58e-05	0.000246	CcSEcCtD
Doxepin—Hypersensitivity—Trandolapril—coronary artery disease	3.58e-05	0.000246	CcSEcCtD
Doxepin—Dermatitis—Eplerenone—coronary artery disease	3.58e-05	0.000246	CcSEcCtD
Doxepin—Diarrhoea—Valsartan—coronary artery disease	3.58e-05	0.000246	CcSEcCtD
Doxepin—Confusional state—Timolol—coronary artery disease	3.58e-05	0.000246	CcSEcCtD
Doxepin—Shock—Ramipril—coronary artery disease	3.57e-05	0.000245	CcSEcCtD
Doxepin—Hypersensitivity—Enalapril—coronary artery disease	3.57e-05	0.000245	CcSEcCtD
Doxepin—Body temperature increased—Perindopril—coronary artery disease	3.57e-05	0.000245	CcSEcCtD
Doxepin—Abdominal pain—Perindopril—coronary artery disease	3.57e-05	0.000245	CcSEcCtD
Doxepin—Palpitations—Lisinopril—coronary artery disease	3.56e-05	0.000245	CcSEcCtD
Doxepin—Diarrhoea—Olmesartan—coronary artery disease	3.56e-05	0.000245	CcSEcCtD
Doxepin—Headache—Eplerenone—coronary artery disease	3.56e-05	0.000245	CcSEcCtD
Doxepin—Nervous system disorder—Ramipril—coronary artery disease	3.56e-05	0.000245	CcSEcCtD
Doxepin—Thrombocytopenia—Ramipril—coronary artery disease	3.55e-05	0.000244	CcSEcCtD
Doxepin—Oedema—Timolol—coronary artery disease	3.55e-05	0.000244	CcSEcCtD
Doxepin—Pruritus—Pravastatin—coronary artery disease	3.54e-05	0.000244	CcSEcCtD
Doxepin—Loss of consciousness—Lisinopril—coronary artery disease	3.54e-05	0.000244	CcSEcCtD
Doxepin—Nausea—Clopidogrel—coronary artery disease	3.54e-05	0.000243	CcSEcCtD
Doxepin—Tachycardia—Ramipril—coronary artery disease	3.54e-05	0.000243	CcSEcCtD
Doxepin—Skin disorder—Ramipril—coronary artery disease	3.52e-05	0.000242	CcSEcCtD
Doxepin—Infection—Timolol—coronary artery disease	3.52e-05	0.000242	CcSEcCtD
Doxepin—Vomiting—Simvastatin—coronary artery disease	3.52e-05	0.000242	CcSEcCtD
Doxepin—Hypersensitivity—Telmisartan—coronary artery disease	3.52e-05	0.000242	CcSEcCtD
Doxepin—Cough—Lisinopril—coronary artery disease	3.52e-05	0.000242	CcSEcCtD
Doxepin—Nausea—Lovastatin—coronary artery disease	3.52e-05	0.000242	CcSEcCtD
Doxepin—Hyperhidrosis—Ramipril—coronary artery disease	3.51e-05	0.000241	CcSEcCtD
Doxepin—Rash—Simvastatin—coronary artery disease	3.49e-05	0.00024	CcSEcCtD
Doxepin—Dermatitis—Simvastatin—coronary artery disease	3.49e-05	0.00024	CcSEcCtD
Doxepin—Asthenia—Trandolapril—coronary artery disease	3.49e-05	0.00024	CcSEcCtD
Doxepin—Shock—Timolol—coronary artery disease	3.49e-05	0.00024	CcSEcCtD
Doxepin—Feeling abnormal—Losartan—coronary artery disease	3.49e-05	0.00024	CcSEcCtD
Doxepin—Urticaria—Furosemide—coronary artery disease	3.48e-05	0.000239	CcSEcCtD
Doxepin—Diarrhoea—Niacin—coronary artery disease	3.48e-05	0.000239	CcSEcCtD
Doxepin—Nervous system disorder—Timolol—coronary artery disease	3.48e-05	0.000239	CcSEcCtD
Doxepin—Asthenia—Enalapril—coronary artery disease	3.48e-05	0.000239	CcSEcCtD
Doxepin—Headache—Simvastatin—coronary artery disease	3.47e-05	0.000239	CcSEcCtD
Doxepin—Body temperature increased—Furosemide—coronary artery disease	3.47e-05	0.000238	CcSEcCtD
Doxepin—Abdominal pain—Furosemide—coronary artery disease	3.47e-05	0.000238	CcSEcCtD
Doxepin—Gastrointestinal pain—Losartan—coronary artery disease	3.46e-05	0.000238	CcSEcCtD
Doxepin—Dizziness—Valsartan—coronary artery disease	3.46e-05	0.000238	CcSEcCtD
Doxepin—Anorexia—Ramipril—coronary artery disease	3.46e-05	0.000238	CcSEcCtD
Doxepin—Nausea—Ezetimibe—coronary artery disease	3.45e-05	0.000237	CcSEcCtD
Doxepin—Skin disorder—Timolol—coronary artery disease	3.45e-05	0.000237	CcSEcCtD
Doxepin—Dizziness—Olmesartan—coronary artery disease	3.44e-05	0.000237	CcSEcCtD
Doxepin—Pruritus—Trandolapril—coronary artery disease	3.44e-05	0.000236	CcSEcCtD
Doxepin—Chest pain—Lisinopril—coronary artery disease	3.43e-05	0.000236	CcSEcCtD
Doxepin—Arthralgia—Lisinopril—coronary artery disease	3.43e-05	0.000236	CcSEcCtD
Doxepin—Myalgia—Lisinopril—coronary artery disease	3.43e-05	0.000236	CcSEcCtD
Doxepin—Hyperhidrosis—Timolol—coronary artery disease	3.43e-05	0.000236	CcSEcCtD
Doxepin—Asthenia—Telmisartan—coronary artery disease	3.43e-05	0.000236	CcSEcCtD
Doxepin—Pruritus—Enalapril—coronary artery disease	3.43e-05	0.000236	CcSEcCtD
Doxepin—Diarrhoea—Pravastatin—coronary artery disease	3.43e-05	0.000236	CcSEcCtD
Doxepin—Anxiety—Lisinopril—coronary artery disease	3.42e-05	0.000235	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	3.41e-05	0.000234	CcSEcCtD
Doxepin—Discomfort—Lisinopril—coronary artery disease	3.39e-05	0.000233	CcSEcCtD
Doxepin—Hypotension—Ramipril—coronary artery disease	3.39e-05	0.000233	CcSEcCtD
Doxepin—Anorexia—Timolol—coronary artery disease	3.38e-05	0.000232	CcSEcCtD
Doxepin—Pruritus—Telmisartan—coronary artery disease	3.38e-05	0.000232	CcSEcCtD
Doxepin—Nausea—Eplerenone—coronary artery disease	3.38e-05	0.000232	CcSEcCtD
Doxepin—Dizziness—Niacin—coronary artery disease	3.36e-05	0.000231	CcSEcCtD
Doxepin—Urticaria—Losartan—coronary artery disease	3.36e-05	0.000231	CcSEcCtD
Doxepin—Dry mouth—Lisinopril—coronary artery disease	3.36e-05	0.000231	CcSEcCtD
Doxepin—Body temperature increased—Losartan—coronary artery disease	3.35e-05	0.00023	CcSEcCtD
Doxepin—Abdominal pain—Losartan—coronary artery disease	3.35e-05	0.00023	CcSEcCtD
Doxepin—Asthenia—Captopril—coronary artery disease	3.33e-05	0.000229	CcSEcCtD
Doxepin—Diarrhoea—Trandolapril—coronary artery disease	3.33e-05	0.000229	CcSEcCtD
Doxepin—Vomiting—Valsartan—coronary artery disease	3.33e-05	0.000229	CcSEcCtD
Doxepin—Confusional state—Lisinopril—coronary artery disease	3.32e-05	0.000228	CcSEcCtD
Doxepin—Diarrhoea—Enalapril—coronary artery disease	3.31e-05	0.000228	CcSEcCtD
Doxepin—Hypotension—Timolol—coronary artery disease	3.31e-05	0.000228	CcSEcCtD
Doxepin—Dizziness—Pravastatin—coronary artery disease	3.31e-05	0.000228	CcSEcCtD
Doxepin—Vomiting—Olmesartan—coronary artery disease	3.31e-05	0.000228	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Ramipril—coronary artery disease	3.31e-05	0.000227	CcSEcCtD
Doxepin—Rash—Valsartan—coronary artery disease	3.3e-05	0.000227	CcSEcCtD
Doxepin—Dermatitis—Valsartan—coronary artery disease	3.3e-05	0.000227	CcSEcCtD
Doxepin—Nausea—Simvastatin—coronary artery disease	3.29e-05	0.000226	CcSEcCtD
Doxepin—Oedema—Lisinopril—coronary artery disease	3.29e-05	0.000226	CcSEcCtD
Doxepin—Pruritus—Captopril—coronary artery disease	3.29e-05	0.000226	CcSEcCtD
Doxepin—Rash—Olmesartan—coronary artery disease	3.28e-05	0.000226	CcSEcCtD
Doxepin—Insomnia—Ramipril—coronary artery disease	3.28e-05	0.000226	CcSEcCtD
Doxepin—Dermatitis—Olmesartan—coronary artery disease	3.28e-05	0.000225	CcSEcCtD
Doxepin—Headache—Valsartan—coronary artery disease	3.28e-05	0.000225	CcSEcCtD
Doxepin—Diarrhoea—Telmisartan—coronary artery disease	3.27e-05	0.000225	CcSEcCtD
Doxepin—Infection—Lisinopril—coronary artery disease	3.27e-05	0.000225	CcSEcCtD
Doxepin—Headache—Olmesartan—coronary artery disease	3.26e-05	0.000224	CcSEcCtD
Doxepin—Paraesthesia—Ramipril—coronary artery disease	3.26e-05	0.000224	CcSEcCtD
Doxepin—Clomipramine—HTR2A—coronary artery disease	3.25e-05	0.0108	CrCbGaD
Doxepin—Shock—Lisinopril—coronary artery disease	3.24e-05	0.000222	CcSEcCtD
Doxepin—Asthenia—Perindopril—coronary artery disease	3.24e-05	0.000222	CcSEcCtD
Doxepin—Dyspnoea—Ramipril—coronary artery disease	3.23e-05	0.000222	CcSEcCtD
Doxepin—Chlorprothixene—HTR2A—coronary artery disease	3.23e-05	0.0107	CrCbGaD
Doxepin—Vomiting—Niacin—coronary artery disease	3.23e-05	0.000222	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Timolol—coronary artery disease	3.23e-05	0.000222	CcSEcCtD
Doxepin—Hypersensitivity—Furosemide—coronary artery disease	3.23e-05	0.000222	CcSEcCtD
Doxepin—Somnolence—Ramipril—coronary artery disease	3.23e-05	0.000222	CcSEcCtD
Doxepin—Desipramine—CYP2C19—coronary artery disease	3.22e-05	0.0107	CrCbGaD
Doxepin—Thrombocytopenia—Lisinopril—coronary artery disease	3.22e-05	0.000221	CcSEcCtD
Doxepin—Dizziness—Trandolapril—coronary artery disease	3.22e-05	0.000221	CcSEcCtD
Doxepin—Tachycardia—Lisinopril—coronary artery disease	3.21e-05	0.000221	CcSEcCtD
Doxepin—Insomnia—Timolol—coronary artery disease	3.21e-05	0.00022	CcSEcCtD
Doxepin—Rash—Niacin—coronary artery disease	3.21e-05	0.00022	CcSEcCtD
Doxepin—Dermatitis—Niacin—coronary artery disease	3.2e-05	0.00022	CcSEcCtD
Doxepin—Dizziness—Enalapril—coronary artery disease	3.2e-05	0.00022	CcSEcCtD
Doxepin—Skin disorder—Lisinopril—coronary artery disease	3.2e-05	0.00022	CcSEcCtD
Doxepin—Dyspepsia—Ramipril—coronary artery disease	3.19e-05	0.000219	CcSEcCtD
Doxepin—Pruritus—Perindopril—coronary artery disease	3.19e-05	0.000219	CcSEcCtD
Doxepin—Headache—Niacin—coronary artery disease	3.19e-05	0.000219	CcSEcCtD
Doxepin—Paraesthesia—Timolol—coronary artery disease	3.19e-05	0.000219	CcSEcCtD
Doxepin—Vomiting—Pravastatin—coronary artery disease	3.18e-05	0.000219	CcSEcCtD
Doxepin—Hyperhidrosis—Lisinopril—coronary artery disease	3.18e-05	0.000219	CcSEcCtD
Doxepin—Diarrhoea—Captopril—coronary artery disease	3.18e-05	0.000218	CcSEcCtD
Doxepin—Nortriptyline—HTR2A—coronary artery disease	3.17e-05	0.0105	CrCbGaD
Doxepin—Dyspnoea—Timolol—coronary artery disease	3.16e-05	0.000217	CcSEcCtD
Doxepin—Dizziness—Telmisartan—coronary artery disease	3.16e-05	0.000217	CcSEcCtD
Doxepin—Rash—Pravastatin—coronary artery disease	3.16e-05	0.000217	CcSEcCtD
Doxepin—Dermatitis—Pravastatin—coronary artery disease	3.16e-05	0.000217	CcSEcCtD
Doxepin—Decreased appetite—Ramipril—coronary artery disease	3.15e-05	0.000217	CcSEcCtD
Doxepin—Somnolence—Timolol—coronary artery disease	3.15e-05	0.000217	CcSEcCtD
Doxepin—Asthenia—Furosemide—coronary artery disease	3.15e-05	0.000216	CcSEcCtD
Doxepin—Headache—Pravastatin—coronary artery disease	3.14e-05	0.000216	CcSEcCtD
Doxepin—Anorexia—Lisinopril—coronary artery disease	3.14e-05	0.000216	CcSEcCtD
Doxepin—Gastrointestinal disorder—Ramipril—coronary artery disease	3.13e-05	0.000215	CcSEcCtD
Doxepin—Fatigue—Ramipril—coronary artery disease	3.13e-05	0.000215	CcSEcCtD
Doxepin—Promazine—CYP2C19—coronary artery disease	3.12e-05	0.0104	CrCbGaD
Doxepin—Dyspepsia—Timolol—coronary artery disease	3.12e-05	0.000215	CcSEcCtD
Doxepin—Hypersensitivity—Losartan—coronary artery disease	3.12e-05	0.000214	CcSEcCtD
Doxepin—Nausea—Valsartan—coronary artery disease	3.11e-05	0.000214	CcSEcCtD
Doxepin—Pruritus—Furosemide—coronary artery disease	3.1e-05	0.000213	CcSEcCtD
Doxepin—Constipation—Ramipril—coronary artery disease	3.1e-05	0.000213	CcSEcCtD
Doxepin—Nausea—Olmesartan—coronary artery disease	3.09e-05	0.000213	CcSEcCtD
Doxepin—Vomiting—Trandolapril—coronary artery disease	3.09e-05	0.000213	CcSEcCtD
Doxepin—Diarrhoea—Perindopril—coronary artery disease	3.09e-05	0.000212	CcSEcCtD
Doxepin—Decreased appetite—Timolol—coronary artery disease	3.08e-05	0.000212	CcSEcCtD
Doxepin—Vomiting—Enalapril—coronary artery disease	3.08e-05	0.000212	CcSEcCtD
Doxepin—Hypotension—Lisinopril—coronary artery disease	3.07e-05	0.000211	CcSEcCtD
Doxepin—Dizziness—Captopril—coronary artery disease	3.07e-05	0.000211	CcSEcCtD
Doxepin—Rash—Trandolapril—coronary artery disease	3.07e-05	0.000211	CcSEcCtD
Doxepin—Dermatitis—Trandolapril—coronary artery disease	3.06e-05	0.000211	CcSEcCtD
Doxepin—Gastrointestinal disorder—Timolol—coronary artery disease	3.06e-05	0.00021	CcSEcCtD
Doxepin—Fatigue—Timolol—coronary artery disease	3.06e-05	0.00021	CcSEcCtD
Doxepin—Rash—Enalapril—coronary artery disease	3.05e-05	0.00021	CcSEcCtD
Doxepin—Dermatitis—Enalapril—coronary artery disease	3.05e-05	0.00021	CcSEcCtD
Doxepin—Headache—Trandolapril—coronary artery disease	3.05e-05	0.000209	CcSEcCtD
Doxepin—Vomiting—Telmisartan—coronary artery disease	3.04e-05	0.000209	CcSEcCtD
Doxepin—Asthenia—Losartan—coronary artery disease	3.04e-05	0.000209	CcSEcCtD
Doxepin—Headache—Enalapril—coronary artery disease	3.03e-05	0.000209	CcSEcCtD
Doxepin—Pain—Timolol—coronary artery disease	3.03e-05	0.000208	CcSEcCtD
Doxepin—Nausea—Niacin—coronary artery disease	3.02e-05	0.000208	CcSEcCtD
Doxepin—Rash—Telmisartan—coronary artery disease	3.01e-05	0.000207	CcSEcCtD
Doxepin—Dermatitis—Telmisartan—coronary artery disease	3.01e-05	0.000207	CcSEcCtD
Doxepin—Diarrhoea—Furosemide—coronary artery disease	3e-05	0.000206	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Lisinopril—coronary artery disease	3e-05	0.000206	CcSEcCtD
Doxepin—Pruritus—Losartan—coronary artery disease	2.99e-05	0.000206	CcSEcCtD
Doxepin—Headache—Telmisartan—coronary artery disease	2.99e-05	0.000206	CcSEcCtD
Doxepin—Feeling abnormal—Ramipril—coronary artery disease	2.99e-05	0.000205	CcSEcCtD
Doxepin—Trimipramine—HTR2A—coronary artery disease	2.99e-05	0.00992	CrCbGaD
Doxepin—Dizziness—Perindopril—coronary artery disease	2.98e-05	0.000205	CcSEcCtD
Doxepin—Insomnia—Lisinopril—coronary artery disease	2.98e-05	0.000205	CcSEcCtD
Doxepin—Nausea—Pravastatin—coronary artery disease	2.98e-05	0.000204	CcSEcCtD
Doxepin—Gastrointestinal pain—Ramipril—coronary artery disease	2.97e-05	0.000204	CcSEcCtD
Doxepin—Paraesthesia—Lisinopril—coronary artery disease	2.95e-05	0.000203	CcSEcCtD
Doxepin—Vomiting—Captopril—coronary artery disease	2.95e-05	0.000203	CcSEcCtD
Doxepin—Dyspnoea—Lisinopril—coronary artery disease	2.93e-05	0.000202	CcSEcCtD
Doxepin—Rash—Captopril—coronary artery disease	2.93e-05	0.000201	CcSEcCtD
Doxepin—Dermatitis—Captopril—coronary artery disease	2.93e-05	0.000201	CcSEcCtD
Doxepin—Somnolence—Lisinopril—coronary artery disease	2.93e-05	0.000201	CcSEcCtD
Doxepin—Feeling abnormal—Timolol—coronary artery disease	2.92e-05	0.000201	CcSEcCtD
Doxepin—Headache—Captopril—coronary artery disease	2.91e-05	0.0002	CcSEcCtD
Doxepin—Gastrointestinal pain—Timolol—coronary artery disease	2.9e-05	0.000199	CcSEcCtD
Doxepin—Dizziness—Furosemide—coronary artery disease	2.9e-05	0.000199	CcSEcCtD
Doxepin—Dyspepsia—Lisinopril—coronary artery disease	2.9e-05	0.000199	CcSEcCtD
Doxepin—Diarrhoea—Losartan—coronary artery disease	2.9e-05	0.000199	CcSEcCtD
Doxepin—Nausea—Trandolapril—coronary artery disease	2.89e-05	0.000199	CcSEcCtD
Doxepin—Urticaria—Ramipril—coronary artery disease	2.88e-05	0.000198	CcSEcCtD
Doxepin—Promethazine—HTR2A—coronary artery disease	2.88e-05	0.00955	CrCbGaD
Doxepin—Nausea—Enalapril—coronary artery disease	2.88e-05	0.000198	CcSEcCtD
Doxepin—Vomiting—Perindopril—coronary artery disease	2.87e-05	0.000197	CcSEcCtD
Doxepin—Body temperature increased—Ramipril—coronary artery disease	2.87e-05	0.000197	CcSEcCtD
Doxepin—Abdominal pain—Ramipril—coronary artery disease	2.87e-05	0.000197	CcSEcCtD
Doxepin—Decreased appetite—Lisinopril—coronary artery disease	2.86e-05	0.000197	CcSEcCtD
Doxepin—Rash—Perindopril—coronary artery disease	2.84e-05	0.000195	CcSEcCtD
Doxepin—Dermatitis—Perindopril—coronary artery disease	2.84e-05	0.000195	CcSEcCtD
Doxepin—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.84e-05	0.000195	CcSEcCtD
Doxepin—Nausea—Telmisartan—coronary artery disease	2.84e-05	0.000195	CcSEcCtD
Doxepin—Fatigue—Lisinopril—coronary artery disease	2.84e-05	0.000195	CcSEcCtD
Doxepin—Headache—Perindopril—coronary artery disease	2.83e-05	0.000194	CcSEcCtD
Doxepin—Urticaria—Timolol—coronary artery disease	2.82e-05	0.000194	CcSEcCtD
Doxepin—Pain—Lisinopril—coronary artery disease	2.81e-05	0.000193	CcSEcCtD
Doxepin—Constipation—Lisinopril—coronary artery disease	2.81e-05	0.000193	CcSEcCtD
Doxepin—Thiothixene—ALB—coronary artery disease	2.81e-05	0.00933	CrCbGaD
Doxepin—Abdominal pain—Timolol—coronary artery disease	2.8e-05	0.000193	CcSEcCtD
Doxepin—Body temperature increased—Timolol—coronary artery disease	2.8e-05	0.000193	CcSEcCtD
Doxepin—Dizziness—Losartan—coronary artery disease	2.8e-05	0.000192	CcSEcCtD
Doxepin—Vomiting—Furosemide—coronary artery disease	2.79e-05	0.000192	CcSEcCtD
Doxepin—Rash—Furosemide—coronary artery disease	2.77e-05	0.00019	CcSEcCtD
Doxepin—Dermatitis—Furosemide—coronary artery disease	2.76e-05	0.00019	CcSEcCtD
Doxepin—Nausea—Captopril—coronary artery disease	2.76e-05	0.00019	CcSEcCtD
Doxepin—Headache—Furosemide—coronary artery disease	2.75e-05	0.000189	CcSEcCtD
Doxepin—Imipramine—CYP2C19—coronary artery disease	2.73e-05	0.00908	CrCbGaD
Doxepin—Amitriptyline—CYP2C19—coronary artery disease	2.72e-05	0.00902	CrCbGaD
Doxepin—Feeling abnormal—Lisinopril—coronary artery disease	2.71e-05	0.000186	CcSEcCtD
Doxepin—Gastrointestinal pain—Lisinopril—coronary artery disease	2.69e-05	0.000185	CcSEcCtD
Doxepin—Vomiting—Losartan—coronary artery disease	2.69e-05	0.000185	CcSEcCtD
Doxepin—Nausea—Perindopril—coronary artery disease	2.68e-05	0.000184	CcSEcCtD
Doxepin—Hypersensitivity—Ramipril—coronary artery disease	2.67e-05	0.000184	CcSEcCtD
Doxepin—Rash—Losartan—coronary artery disease	2.67e-05	0.000183	CcSEcCtD
Doxepin—Dermatitis—Losartan—coronary artery disease	2.67e-05	0.000183	CcSEcCtD
Doxepin—Headache—Losartan—coronary artery disease	2.65e-05	0.000182	CcSEcCtD
Doxepin—Urticaria—Lisinopril—coronary artery disease	2.61e-05	0.00018	CcSEcCtD
Doxepin—Desipramine—HTR2A—coronary artery disease	2.61e-05	0.00868	CrCbGaD
Doxepin—Hypersensitivity—Timolol—coronary artery disease	2.61e-05	0.00018	CcSEcCtD
Doxepin—Nausea—Furosemide—coronary artery disease	2.6e-05	0.000179	CcSEcCtD
Doxepin—Asthenia—Ramipril—coronary artery disease	2.6e-05	0.000179	CcSEcCtD
Doxepin—Body temperature increased—Lisinopril—coronary artery disease	2.6e-05	0.000179	CcSEcCtD
Doxepin—Abdominal pain—Lisinopril—coronary artery disease	2.6e-05	0.000179	CcSEcCtD
Doxepin—Pruritus—Ramipril—coronary artery disease	2.57e-05	0.000176	CcSEcCtD
Doxepin—Asthenia—Timolol—coronary artery disease	2.54e-05	0.000175	CcSEcCtD
Doxepin—Promazine—HTR2A—coronary artery disease	2.53e-05	0.0084	CrCbGaD
Doxepin—Nausea—Losartan—coronary artery disease	2.51e-05	0.000173	CcSEcCtD
Doxepin—Pruritus—Timolol—coronary artery disease	2.51e-05	0.000172	CcSEcCtD
Doxepin—Diarrhoea—Ramipril—coronary artery disease	2.48e-05	0.000171	CcSEcCtD
Doxepin—Diarrhoea—Timolol—coronary artery disease	2.43e-05	0.000167	CcSEcCtD
Doxepin—Hypersensitivity—Lisinopril—coronary artery disease	2.42e-05	0.000167	CcSEcCtD
Doxepin—Dizziness—Ramipril—coronary artery disease	2.4e-05	0.000165	CcSEcCtD
Doxepin—Asthenia—Lisinopril—coronary artery disease	2.36e-05	0.000162	CcSEcCtD
Doxepin—Dizziness—Timolol—coronary artery disease	2.35e-05	0.000161	CcSEcCtD
Doxepin—Pruritus—Lisinopril—coronary artery disease	2.33e-05	0.00016	CcSEcCtD
Doxepin—Vomiting—Ramipril—coronary artery disease	2.31e-05	0.000159	CcSEcCtD
Doxepin—Rash—Ramipril—coronary artery disease	2.29e-05	0.000157	CcSEcCtD
Doxepin—Dermatitis—Ramipril—coronary artery disease	2.29e-05	0.000157	CcSEcCtD
Doxepin—Headache—Ramipril—coronary artery disease	2.27e-05	0.000156	CcSEcCtD
Doxepin—Vomiting—Timolol—coronary artery disease	2.26e-05	0.000155	CcSEcCtD
Doxepin—Diarrhoea—Lisinopril—coronary artery disease	2.25e-05	0.000155	CcSEcCtD
Doxepin—Rash—Timolol—coronary artery disease	2.24e-05	0.000154	CcSEcCtD
Doxepin—Dermatitis—Timolol—coronary artery disease	2.23e-05	0.000154	CcSEcCtD
Doxepin—Clomipramine—ALB—coronary artery disease	2.22e-05	0.00738	CrCbGaD
Doxepin—Headache—Timolol—coronary artery disease	2.22e-05	0.000153	CcSEcCtD
Doxepin—Imipramine—HTR2A—coronary artery disease	2.22e-05	0.00736	CrCbGaD
Doxepin—Amitriptyline—HTR2A—coronary artery disease	2.2e-05	0.00731	CrCbGaD
Doxepin—Dizziness—Lisinopril—coronary artery disease	2.18e-05	0.00015	CcSEcCtD
Doxepin—Nortriptyline—ALB—coronary artery disease	2.17e-05	0.00721	CrCbGaD
Doxepin—Nausea—Ramipril—coronary artery disease	2.16e-05	0.000148	CcSEcCtD
Doxepin—Nausea—Timolol—coronary artery disease	2.11e-05	0.000145	CcSEcCtD
Doxepin—Vomiting—Lisinopril—coronary artery disease	2.09e-05	0.000144	CcSEcCtD
Doxepin—Rash—Lisinopril—coronary artery disease	2.07e-05	0.000143	CcSEcCtD
Doxepin—Dermatitis—Lisinopril—coronary artery disease	2.07e-05	0.000142	CcSEcCtD
Doxepin—Headache—Lisinopril—coronary artery disease	2.06e-05	0.000142	CcSEcCtD
Doxepin—Nausea—Lisinopril—coronary artery disease	1.95e-05	0.000134	CcSEcCtD
Doxepin—Amitriptyline—ALB—coronary artery disease	1.51e-05	0.005	CrCbGaD
Doxepin—CYP2C9—Metabolism—APOE—coronary artery disease	7.56e-07	7.13e-06	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—AKT1—coronary artery disease	7.56e-07	7.12e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CASP3—coronary artery disease	7.55e-07	7.11e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—APOA1—coronary artery disease	7.54e-07	7.11e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	7.54e-07	7.11e-06	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TGFB1—coronary artery disease	7.53e-07	7.1e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—GPX1—coronary artery disease	7.52e-07	7.09e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—AKT1—coronary artery disease	7.52e-07	7.09e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	7.52e-07	7.09e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—IL6—coronary artery disease	7.5e-07	7.06e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MMP9—coronary artery disease	7.49e-07	7.06e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—APOA1—coronary artery disease	7.48e-07	7.05e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CCND1—coronary artery disease	7.46e-07	7.03e-06	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—MAPK1—coronary artery disease	7.46e-07	7.03e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MMP9—coronary artery disease	7.45e-07	7.02e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	7.44e-07	7.01e-06	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—MAPK1—coronary artery disease	7.39e-07	6.96e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GOT1—coronary artery disease	7.35e-07	6.92e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GGT1—coronary artery disease	7.35e-07	6.92e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CCND1—coronary artery disease	7.35e-07	6.92e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	7.34e-07	6.91e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CD36—coronary artery disease	7.33e-07	6.9e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CXCL8—coronary artery disease	7.27e-07	6.85e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	7.26e-07	6.84e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MMP9—coronary artery disease	7.25e-07	6.83e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PPP2CA—coronary artery disease	7.24e-07	6.82e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PPARG—coronary artery disease	7.23e-07	6.81e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	7.23e-07	6.81e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	7.16e-07	6.75e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	7.15e-07	6.74e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CXCL8—coronary artery disease	7.14e-07	6.73e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MMP9—coronary artery disease	7.13e-07	6.72e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	7.13e-07	6.72e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—POMC—coronary artery disease	7.13e-07	6.72e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	7.11e-07	6.7e-06	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—PIK3CA—coronary artery disease	7.09e-07	6.69e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CXCL8—coronary artery disease	7.09e-07	6.68e-06	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TGFB1—coronary artery disease	7.08e-07	6.67e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PPARG—coronary artery disease	7.05e-07	6.65e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—AKT1—coronary artery disease	7.03e-07	6.62e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	7.02e-07	6.62e-06	CbGpPWpGaD
Doxepin—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	7.02e-07	6.62e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	7e-07	6.6e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	6.99e-07	6.58e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—VEGFA—coronary artery disease	6.97e-07	6.56e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CASP3—coronary artery disease	6.96e-07	6.56e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—POMC—coronary artery disease	6.96e-07	6.56e-06	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—MAPK1—coronary artery disease	6.94e-07	6.54e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—MTHFR—coronary artery disease	6.94e-07	6.54e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—AKT1—coronary artery disease	6.92e-07	6.52e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—IL6—coronary artery disease	6.91e-07	6.51e-06	CbGpPWpGaD
Doxepin—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	6.91e-07	6.51e-06	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	6.89e-07	6.5e-06	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	6.87e-07	6.48e-06	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—AKT1—coronary artery disease	6.85e-07	6.46e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CASP3—coronary artery disease	6.85e-07	6.45e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CASP3—coronary artery disease	6.83e-07	6.44e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CASP3—coronary artery disease	6.81e-07	6.42e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—IL6—coronary artery disease	6.8e-07	6.41e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CASP3—coronary artery disease	6.79e-07	6.4e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—IL6—coronary artery disease	6.79e-07	6.4e-06	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	6.78e-07	6.39e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CCND1—coronary artery disease	6.77e-07	6.38e-06	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	6.77e-07	6.38e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—IL6—coronary artery disease	6.76e-07	6.37e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—IL6—coronary artery disease	6.74e-07	6.35e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	6.72e-07	6.34e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CASP3—coronary artery disease	6.72e-07	6.33e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	6.7e-07	6.32e-06	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—PIK3CA—coronary artery disease	6.69e-07	6.31e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	6.69e-07	6.3e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—IL6—coronary artery disease	6.68e-07	6.29e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CCND1—coronary artery disease	6.66e-07	6.28e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	6.66e-07	6.28e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CCND1—coronary artery disease	6.65e-07	6.27e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PPARG—coronary artery disease	6.65e-07	6.26e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CCND1—coronary artery disease	6.63e-07	6.25e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CCND1—coronary artery disease	6.61e-07	6.23e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GSTP1—coronary artery disease	6.6e-07	6.22e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—AGT—coronary artery disease	6.6e-07	6.22e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PPARG—coronary artery disease	6.59e-07	6.21e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MMP9—coronary artery disease	6.57e-07	6.2e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—POMC—coronary artery disease	6.56e-07	6.18e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CCND1—coronary artery disease	6.54e-07	6.17e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	6.54e-07	6.16e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	6.52e-07	6.15e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—HMOX1—coronary artery disease	6.51e-07	6.13e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	6.51e-07	6.13e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—VEGFA—coronary artery disease	6.51e-07	6.13e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—POMC—coronary artery disease	6.5e-07	6.12e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—ALB—coronary artery disease	6.5e-07	6.12e-06	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—PIK3CA—coronary artery disease	6.48e-07	6.1e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MMP9—coronary artery disease	6.47e-07	6.1e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—APOE—coronary artery disease	6.46e-07	6.09e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MMP9—coronary artery disease	6.46e-07	6.08e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MMP9—coronary artery disease	6.43e-07	6.06e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CAT—coronary artery disease	6.42e-07	6.05e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MMP9—coronary artery disease	6.41e-07	6.04e-06	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—PIK3CA—coronary artery disease	6.41e-07	6.04e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—VEGFA—coronary artery disease	6.4e-07	6.03e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TGFB1—coronary artery disease	6.39e-07	6.02e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—APOA1—coronary artery disease	6.39e-07	6.02e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—AKT1—coronary artery disease	6.38e-07	6.01e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MMP9—coronary artery disease	6.35e-07	5.99e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—ALB—coronary artery disease	6.34e-07	5.98e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	6.33e-07	5.97e-06	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	6.29e-07	5.92e-06	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—IL6—coronary artery disease	6.28e-07	5.92e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	6.27e-07	5.91e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MAPK1—coronary artery disease	6.27e-07	5.91e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—AKT1—coronary artery disease	6.26e-07	5.9e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	6.24e-07	5.88e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APOB—coronary artery disease	6.23e-07	5.87e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	6.23e-07	5.87e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—AKT1—coronary artery disease	6.22e-07	5.86e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—NOS3—coronary artery disease	6.22e-07	5.86e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	6.19e-07	5.83e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	6.17e-07	5.82e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	6.16e-07	5.81e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	6.14e-07	5.79e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	6.14e-07	5.79e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	6.12e-07	5.77e-06	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—PIK3CA—coronary artery disease	6.08e-07	5.73e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—NOS3—coronary artery disease	6.07e-07	5.72e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GSTM1—coronary artery disease	6.06e-07	5.71e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	6.06e-07	5.71e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	6.05e-07	5.7e-06	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—PIK3CA—coronary artery disease	6.03e-07	5.68e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	6.02e-07	5.67e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—ALB—coronary artery disease	5.98e-07	5.63e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TGFB1—coronary artery disease	5.97e-07	5.63e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—LPL—coronary artery disease	5.95e-07	5.61e-06	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—IL6—coronary artery disease	5.93e-07	5.58e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—ALB—coronary artery disease	5.92e-07	5.58e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—VEGFA—coronary artery disease	5.9e-07	5.56e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	5.89e-07	5.55e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TGFB1—coronary artery disease	5.88e-07	5.54e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MAPK1—coronary artery disease	5.86e-07	5.52e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	5.81e-07	5.47e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GPX1—coronary artery disease	5.81e-07	5.47e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—VEGFA—coronary artery disease	5.8e-07	5.46e-06	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—AKT1—coronary artery disease	5.8e-07	5.46e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	5.78e-07	5.44e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MAPK1—coronary artery disease	5.76e-07	5.43e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—VEGFA—coronary artery disease	5.76e-07	5.43e-06	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—IL6—coronary artery disease	5.73e-07	5.4e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—NOS3—coronary artery disease	5.72e-07	5.39e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	5.71e-07	5.38e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	5.7e-07	5.37e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	5.69e-07	5.36e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PTGS2—coronary artery disease	5.68e-07	5.36e-06	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—IL6—coronary artery disease	5.68e-07	5.35e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—NOS3—coronary artery disease	5.67e-07	5.34e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CD36—coronary artery disease	5.66e-07	5.33e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PPARG—coronary artery disease	5.63e-07	5.31e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PPP2CA—coronary artery disease	5.58e-07	5.26e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—POMC—coronary artery disease	5.55e-07	5.23e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PTGS2—coronary artery disease	5.55e-07	5.23e-06	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—AKT1—coronary artery disease	5.47e-07	5.15e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—PIK3CA—coronary artery disease	5.44e-07	5.13e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TGFB1—coronary artery disease	5.42e-07	5.11e-06	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—PIK3CA—coronary artery disease	5.38e-07	5.07e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—MTHFR—coronary artery disease	5.36e-07	5.05e-06	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IL6—coronary artery disease	5.34e-07	5.03e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	5.33e-07	5.02e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TGFB1—coronary artery disease	5.32e-07	5.01e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MAPK1—coronary artery disease	5.31e-07	5.01e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	5.3e-07	5e-06	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—AKT1—coronary artery disease	5.29e-07	4.99e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TGFB1—coronary artery disease	5.29e-07	4.98e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	5.28e-07	4.98e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	5.25e-07	4.95e-06	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—AKT1—coronary artery disease	5.24e-07	4.93e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	5.23e-07	4.93e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	5.23e-07	4.93e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PTGS2—coronary artery disease	5.23e-07	4.93e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	5.22e-07	4.92e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	5.22e-07	4.92e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MAPK1—coronary artery disease	5.22e-07	4.92e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	5.2e-07	4.9e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MAPK1—coronary artery disease	5.18e-07	4.89e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PTGS2—coronary artery disease	5.18e-07	4.88e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	5.13e-07	4.84e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	5.12e-07	4.82e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—AGT—coronary artery disease	5.09e-07	4.8e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—PIK3CA—coronary artery disease	5.08e-07	4.79e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—ALB—coronary artery disease	5.06e-07	4.77e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—PIK3CA—coronary artery disease	5e-07	4.71e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APOE—coronary artery disease	4.99e-07	4.7e-06	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—AKT1—coronary artery disease	4.96e-07	4.68e-06	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—PIK3CA—coronary artery disease	4.94e-07	4.65e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APOA1—coronary artery disease	4.93e-07	4.65e-06	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—AKT1—coronary artery disease	4.92e-07	4.64e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	4.85e-07	4.57e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—NOS3—coronary artery disease	4.84e-07	4.56e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IL6—coronary artery disease	4.82e-07	4.54e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	4.76e-07	4.48e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IL6—coronary artery disease	4.65e-07	4.38e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IL6—coronary artery disease	4.63e-07	4.36e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	4.61e-07	4.35e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	4.54e-07	4.28e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	4.53e-07	4.27e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	4.51e-07	4.25e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IL6—coronary artery disease	4.5e-07	4.24e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—PIK3CA—coronary artery disease	4.5e-07	4.24e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	4.45e-07	4.2e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—AKT1—coronary artery disease	4.44e-07	4.19e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	4.44e-07	4.19e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PTGS2—coronary artery disease	4.43e-07	4.17e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IL6—coronary artery disease	4.43e-07	4.17e-06	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—AKT1—coronary artery disease	4.39e-07	4.14e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PPARG—coronary artery disease	4.35e-07	4.09e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—AKT1—coronary artery disease	4.29e-07	4.04e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—POMC—coronary artery disease	4.29e-07	4.04e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—AKT1—coronary artery disease	4.27e-07	4.02e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—AKT1—coronary artery disease	4.15e-07	3.91e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	4.13e-07	3.89e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—AKT1—coronary artery disease	4.09e-07	3.85e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL6—coronary artery disease	4.08e-07	3.85e-06	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—AKT1—coronary artery disease	4.03e-07	3.8e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL6—coronary artery disease	4.02e-07	3.79e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL6—coronary artery disease	4.01e-07	3.78e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL6—coronary artery disease	4e-07	3.77e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL6—coronary artery disease	3.98e-07	3.75e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL6—coronary artery disease	3.94e-07	3.72e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL6—coronary artery disease	3.93e-07	3.71e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ALB—coronary artery disease	3.91e-07	3.68e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—AKT1—coronary artery disease	3.77e-07	3.55e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—NOS3—coronary artery disease	3.74e-07	3.52e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—AKT1—coronary artery disease	3.71e-07	3.49e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—AKT1—coronary artery disease	3.7e-07	3.49e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—AKT1—coronary artery disease	3.69e-07	3.47e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—AKT1—coronary artery disease	3.67e-07	3.46e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL6—coronary artery disease	3.66e-07	3.44e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—AKT1—coronary artery disease	3.64e-07	3.43e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	3.63e-07	3.42e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PIK3CA—coronary artery disease	3.5e-07	3.3e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PTGS2—coronary artery disease	3.42e-07	3.22e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PIK3CA—coronary artery disease	3.41e-07	3.22e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	3.37e-07	3.18e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PIK3CA—coronary artery disease	3.22e-07	3.03e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PIK3CA—coronary artery disease	3.19e-07	3.01e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—AKT1—coronary artery disease	2.86e-07	2.69e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—AKT1—coronary artery disease	2.79e-07	2.63e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3CA—coronary artery disease	2.73e-07	2.57e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—AKT1—coronary artery disease	2.63e-07	2.48e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—AKT1—coronary artery disease	2.61e-07	2.45e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—AKT1—coronary artery disease	2.23e-07	2.1e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3CA—coronary artery disease	2.1e-07	1.98e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—AKT1—coronary artery disease	1.72e-07	1.62e-06	CbGpPWpGaD
